Fengping Peng

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Feng-ping Peng
Publication record
20 papers · 115 citations · H-index 7

PAPERS

Kaempferol Induces Mitophagy and Disrupts Iron Metabolism via SFXN2 Leading to Apoptosis in Multiple Myeloma Cells.
20252 citationsauthor #6
Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma
20250 citationsauthor #10
T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma
20252 citationsauthor #1
Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
20253 citationsauthor #3
Correction: Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
20250 citationsauthor #3
Case report: Carbamazepine-induced thrombocytopenia complicated with severe skin reactions.
20240 citationsauthor #1
T-Lymphocyte Suppression By ULK2 High Expression of CD14+ Monocytes in Patients with Multiple Myeloma
20240 citationsauthor #1
Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
20237 citationsauthor #4
Gene therapy with B‐cell maturation antigen/CD3 bispecific antibody encoding plasmid DNA for treating multiple myeloma
20221 citationsauthor #1
Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes
202212 citationsauthor #6
Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease
20222 citationsauthor #1
Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
202110 citationsauthor #3
CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease
201912 citationsauthor #4
High serum levels of complements C3 and C4 as novel markers for myeloma bone disease
20178 citationsauthor #8
CYR61/CCN1 stimulates proliferation and differentiation of osteoblasts in vitro and contributes to bone remodeling in vivo in myeloma bone disease.
201731 citationsauthor #2
Clinical significance of osteoblast precursors and osteoclast precursors in earlier diagnosis and monitoring of myeloma bone disease
20169 citationsauthor #2
[Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease].
20152 citationsauthor #1
[The bone turnover markers of myeloma bone disease].
20140 citationsauthor #1
Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
201410 citationsauthor #3

TIMELINE

2014 10 citations

2015 2 citations

2016 9 citations

2017 39 citations

2019 12 citations

2021 10 citations

2022 15 citations

2023 7 citations

2024 0 citations

2025 7 citations

Fengping Peng

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT